3rd Drug Development Forum
October 1–3, 2018 | Hilton Boston Logan Airport Hotel
Executive-level networking for smarter partnerships and pipeline strategies, more effective development, and improved early research outcomes
FIERCEBIOTECH DRUG DEVELOPMENT FORUM
Where industry leaders set partnership and pipeline strategy
The FierceBiotech Drug Development Forum is an incomparable networking venue where hundreds of biotech C-suite decision makers tackle the greatest problems the industry faces in business development and early R&D.
Our all-new program features unprecedented depth on managing VC relationships, beating ambitious growth plans, developing your immuno-oncology business model, adapting to new regulatory and pricing realities, and maintaining competitive advantage after the next market downturn.
2018 Featured Speakers
Stephane Bancel
CEO
MODERNA THERAPEUTICS
Roy Baynes
CMO, Senior Vice President, Head of Clinical Development
MERCK
Lawrence Bloch
President
INFINITY PHARMACEUTICALS
Nouhad Husseini
Vice President, Head of Business Development
REGENERON
Douglas Ingram
CEO
SAREPTA THERAPEUTICS
Ravi Kiron
Head, BioPharma External Innovation
EMD SERONO
Julie Krop
CMO
AMAG PHARMACEUTICALS
Salim Mujais
Senior Vice President, Global Therapeutics Head, Specialty Pharma
ASTELLAS
Sridhar Ramaswamy
Vice President, Translational R&D
TESARO
Aradhana Sarin
Senior Vice President, Head of Business Development & Strategy
ALEXION PHARMACEUTICALS
Jeremy Sohn
Vice President, Global Head of Digital Business Development & Licensing
NOVARTIS
Zhen Su
CMO
EMD SERONO
2018 KEYNOTE SPEAKERS
KEYNOTE: Pursue Breakthrough Approvals in Multiple Global Markets
TUESDAY, OCTOBER 2, 2018
MODERATOR: Eric Palmer, Editor, FIERCEMARKETS
Martine Zimmerman, Senior Vice President, Global Regulatory Affairs, ALEXION PHARMACEUTICALS
Roy Baynes, CMO, Senior Vice President, Head of Clinical Development, MERCK
Maria Fardis, CEO, IOVANCE
Julian Adams, CEO, GAMIDA CELL
Fierce 15 winners: What does it take to be fierce in today's biotech market?
2018 SPONSORING ORGANIZATIONS
